MAFA
XYL icon

MJT & Associates Financial Advisory’s Xylem XYL Stock Holding History

MJT & Associates Financial Advisory’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.86K Buy
48
+12
+33% +$1.37K ﹤0.01% 273
2026
Q2 		$4.26K Hold
36
– – ﹤0.01% 295
2026
Q1 		$4.3K Hold
36
– – ﹤0.01% 286
2025
Q4 		$4.9K Hold
36
– – ﹤0.01% 283
2025
Q3 		$5.31K Sell
36
-17
-32% -$2.36K ﹤0.01% 281
2025
Q2 		$6.86K Hold
53
– – 0.01% 266
2025
Q1 		$6.33K Buy
+53
New +$6.57K 0.01% 274

Other funds holding XYL

DS
Dudley & Shanley Palm Beach, Florida $629M AUM 7.61% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
CNBT
Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
CNTOF
Canandaigua National Trust of Florida Canandaigua, New York $181M AUM

MJT & Associates Financial Advisory's XYL Position: Q3 2026 in Review

MJT & Associates Financial Advisory increased its Xylem (XYL) stake by 33% in Q3 2026, buying an estimated $1.37K and bringing the position to 48 shares worth $4.86K. The position accounts for ﹤0.01% of the portfolio, ranked #273.

MJT & Associates Financial Advisory first reported a position in XYL in Q1 2025 and has held it in 7 quarters since. The position peaked at $6.86K in Q2 2025. 34 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • MJT & Associates Financial Advisory held 48 shares of Xylem worth $4.86K as of Q3 2026.
  • MJT & Associates Financial Advisory bought 12 Xylem shares in Q3 2026, an estimated $1.37K.
  • Xylem made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q3 2026, its #273 holding.
  • MJT & Associates Financial Advisory first reported a position in Xylem in Q1 2025 and has held it in 7 quarters since.
  • MJT & Associates Financial Advisory's Xylem position peaked at $6.86K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.